logo
A Lego approach helps prepare Manhattan Associates' TMS for tariff chaos

A Lego approach helps prepare Manhattan Associates' TMS for tariff chaos

Yahoo30-05-2025
LAS VEGAS – Manhattan Associates has been in the transportation management system sector for about 15 years, taking a big step forward with its integrated Active platform in 2021.
But users of its TMS, which is designed to focus on shippers, are dealing with a new set of challenges brought on by the potential supply chain chaos created by tariffs, real and anticipated.
Bryant Smyth is the director of product management at Manhattan Associates (NASDAQ: MANH) with a focus on the company's transportation management capabilities. It's his team that is going to need to direct the company's TMS customers to help limit the pain points and be flexible as the landscape shifts.'You need to have the visibility into which lanes, which customers and which vendors are going to be impacted by these tariffs, especially on the import side, if you're working with vendors who are importing from the other parts of the world,' Smyth said in an interview at Manhattan Associates' Momentum meeting of customers and partners. 'You may need to source a different vendor from a different part of the world, or even move it stateside. So now you're going to be changing not only your vendor relationships, but you're also going to be changing the lanes you're shipping on.'
Smyth said within the Manhattan TMS, it can do 'modeling exercises' that take those various new inputs, combine them with what's still in place and answer the question, 'What does that cost look like with a change in lanes, a different carrier mix and also maybe a change in modalities?'
To provide that sort of service, one of the features of Manhattan Associates' TMS, touted by executives like Smyth at Momentum, involves two terms they use frequently: 'micro' and 'Lego.'
Yes, Lego as in the bricks.Trying to adapt a TMS for individual requirements in legacy systems – the type of need that might be created by a sudden shift in tariff policy – meant 'you write a line of code, and then more lines of code, and now it just becomes this big monolith that the application can do,' Smyth said.
But that is not always the case for a customer working with software installed on its own systems rather than on Manhattan Associates' products in the cloud.
Smyth said the split between customers who are using Manhattan Associates' cloud-based technical capabilities and those who are known as 'on prem' – with the software installed on a customer's system rather than accessing the cloud – is about 50-50.
While it is easy to knock those who remain tied to an on-prem system for lagging behind the growing industry standard of cloud technology, Smyth said those customers do have the advantage of being able to make changes in their system themselves without worrying about how it might affect other users.
The microservice 'Lego' capabilities of Manhattan Associates' TMS, he said, are the 'best of both worlds.' The ability to create a bespoke process unique to a customer similar to what an on-prem user can perform now is available for cloud-based users as well, Smyth said.
The microcapabilities that Manhattan touted at Momentum, based on the use of underlying APIs, draw the comparison to Lego bricks.
'What that allows us to do is that customers need only to activate components that they're going to use,' Smyth said. 'We compartmentalize it so that a particular workflow is centered around a particular action. We break them apart, and then you can put them together as Lego pieces and compose the TMS that you need.'
No conference about software services today for the supply chain can go very far without a discussion of AI. Momentum this year was no different.A year ago at Momentum, a key focus was on generative AI and how it could be used in various Manhattan applications.
New 'agentic' AI tools were rolled out at Momentum this year. And they were part of what Smyth talked about in an interview with FreightWaves, when he looked over his company's TMS and what it was going to need to be able to provide users as they navigate the tariff jungle.
With so much focus last year on generative AI and this year on agentic AI – with an AI-based tool performing the work that a human agent might have performed earlier – Smyth was blunt in addressing a possible weak spot in AI: Is the data good enough for the tools?
AI tools, Smyth said, 'are good only if you see something that you need to be able to take action against.' Given that, Smyth said Manhattan Associates has been working with customers to review what they have, 'visualize it end to end' and 'streamline' the data so it can be used in AI tools, whether it's generative AI or agentic AI.
Asked for an example of what agentic AI can do, Smyth was succinct: 'If I needed to schedule an appointment, you can have an agent do that for you,' he said.
But the process needs to be basic for users. 'Our end users are not all technical; they aren't software developers,' he said. 'They need to be able to tell an agent to do something in a natural language, like 'reschedule this appointment.''
That could kick off actions by multiple agents.
'I might have an agent that looks at my shipments and tells me which ones are late,' he said in reviewing the process. Another might take a late shipment and reschedule it. A third might send a notification to a carrier that there's been a rescheduling.
'Those are three independent agents that you can now cluster together into an automated process,' he said.
This is during a time when supply chain software companies, at least those that are publicly traded, are struggling, at least as evidenced in their stock price.
Manhattan Associates has traded near $188 this week, down from about $228 when Momentum was held in 2024.
Just a few days after the close of the Momentum meeting, supply chain software provider e2open announced it was being sold to WiseTech, an Australian company. E2open had seen a long decline in its stock price going back years, with its earnings reports and analyst calls often lamenting it was tough in that field to get anything done. Its stock was down about 75% in five years after getting a final boost from the sale.
Manhattan Associates' stock price has not suffered as much, but it too has struggled. In the past year, it has swung from a 52-week peak of $312.60 on Dec. 12 – an all-time high – to a low of $140.81 on April 7.
Company executives have talked about difficulties in closing deals.
Smyth said sales are still hitting headwinds, particularly in industries where tariffs are a key issue. 'They're just sitting tight and seeing how things are going to play out,' he said. 'They don't want to make these big capital investments in enterprise software right now.'
More articles by John Kingston
Georgia tort reform aims to change practices in judicial 'hell hole'
Double whammy for Wabash: 2 key agencies cut debt rating on trailer builder
Despite red ink at Heartland, Morgan Stanley report relatively upbeat
The post A Lego approach helps prepare Manhattan Associates' TMS for tariff chaos appeared first on FreightWaves.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

Associated Press

time11 minutes ago

  • Associated Press

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

New York, New York--(Newsfile Corp. - August 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Luminar Technologies, Inc. (NASDAQ: LAZR) between March 20, 2025 and May 14, 2025, both dates inclusive (the 'Class Period'), of the important September 22, 2025 lead plaintiff deadline. SO WHAT: If you purchased Luminar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Luminar class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 22, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) Austin Russell ('Russell'), Luminar's President, CEO and Chairman of the Board, was engaged in undisclosed conduct that would make him the subject of an inquiry by the Audit Committee of the Board of Directors; (2) this conduct created material risk that Russell would be released form his positions at Luminar; (3) Luminar's loss of Russell as an employee would then create material risk of adversely affecting Luminar's business by making it more difficult to compete with other market participants, manage R&D activities, and retain existing customers or cultivate new ones. Further, negative public perception and negative news related to Russell could adversely affect Luminar's brand relationships with customers, or standing in the industry; (4) accordingly, Luminar had no reasonable basis to provide and/or maintain Luminar's financial guidance; and (5) as a result, defendants' public statements were materially false and/or misleading at all times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Luminar class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit

PureTech Health: Notice of Half-Yearly Results
PureTech Health: Notice of Half-Yearly Results

Associated Press

time12 minutes ago

  • Associated Press

PureTech Health: Notice of Half-Yearly Results

BOSTON--(BUSINESS WIRE)--Aug 18, 2025-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company') plans to announce its half-yearly results for the six months ended June 30, 2025, on Thursday, August 28, 2025. A presentation and conference call for analysts and shareholders will take place at 9:00am EDT / 2:00pm BST on the day of publication, and a webcast of the presentation will be available on the Company's website at About PureTech Health PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep portfolio through its experienced research and development team and its extensive network of scientists, clinicians, and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including three that have been approved by the U.S. Food and Drug Administration. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration-enabling studies. All of the underlying programs and platforms that resulted in this portfolio of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points. For more information, visit or connect with us on X (formerly Twitter) @puretechh. Cautionary Note Regarding Forward-Looking Statements This press release contains statements that are or may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation those statements that relate to the timing of the Company's financial reporting and the Company's future prospects, developments, and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks, uncertainties and other important factors that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks, uncertainties and other important factors described under the caption 'Risk Factors' in our Annual Report on Form 20-F for the year ended December 31, 2024, filed with the SEC and in our other regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the Company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, we disclaim any obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. View source version on CONTACT: PureTech Public Relations [email protected] Investor Relations [email protected] KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL HEALTH FDA CLINICAL TRIALS SOURCE: PureTech Health plc Copyright Business Wire 2025. PUB: 08/18/2025 02:00 AM/DISC: 08/18/2025 01:59 AM

Firefly Aerospace eyes Japan rocket launches for Asia market
Firefly Aerospace eyes Japan rocket launches for Asia market

Yahoo

time38 minutes ago

  • Yahoo

Firefly Aerospace eyes Japan rocket launches for Asia market

By Kantaro Komiya TOKYO (Reuters) -Firefly Aerospace is exploring an option to launch its Alpha rocket from Japan as the U.S. rocket maker expands its satellite launch services globally, a Japanese company operating a spaceport in the country's northern Hokkaido said on Monday. The plan could make Japan the second offshore launch site - and first in Asia - for Firefly, the Texas-based rival to Elon Musk's market leader SpaceX, which had its Nasdaq debut earlier this month and is preparing for an Alpha launch in Sweden. Space Cotan, operator of the Hokkaido Spaceport located about 820 km (510 mi) northeast of Tokyo, said it and Firefly signed a preliminary agreement to study the feasibility of launching the small-lift rocket Alpha from there. Launching Alpha from Japan "would allow us to serve the larger satellite industry in Asia and add resiliency for U.S. allies with a proven orbital launch vehicle," Adam Oakes, Firefly's vice president of launch, said in a statement published on Space Cotan's website. A feasibility study would be conducted to assess the regulatory hurdles, timeframe and investments for a launch pad for Alpha in Hokkaido, said Space Cotan spokesperson Ryota Ito. The plan would require a space technology safeguards agreement (TSA) between Washington and Tokyo that would allow American rocket launches in Japan, Ito added. The governments last year kicked off the negotiations but have not reached an agreement. A U.S.-Sweden TSA signed in June cleared the path for Firefly's launches from the Arctic. Four of Firefly's six Alpha flights since 2021 have ended in failure, most recently in April. While Japan's national space agency has launched rockets for decades, private rockets are nascent and most Japanese satellite operators rely on foreign options such as SpaceX's Falcon 9 or Rocket Lab's Electron. Previously, U.S. company Virgin Orbit aimed to use Japan's southwest Oita Airport for launches but the plan was scrapped after the firm went bankrupt in 2023. Colorado-based Sierra Space has an ongoing plan to land its spaceplane on Oita beyond 2027. Taiwanese firm TiSpace last month conducted what could be the first foreign launch in Hokkaido, but the suborbital flight failed within a minute. Japan's government is targeting 30 launches of Japanese rockets a year by the early 2030s and subsidises domestic enterprises such as Space One and Toyota-backed Interstellar Technologies.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store